All Stories

  1. Neurite outgrowth inhibitor-B (Nogo-B) in physiology and disease.

    Article • Physiological Reviews, August 2025, American Physiological Society

    David Long, luigi gnudi

  2. The Prevalence and Progression of Microvascular Complications and the Interaction With Ethnicity and Socioeconomic Status in People With Type 2 Diabetes: A Systematic Review and Meta‐Analysis

    Article • Journal of Diabetes Research, January 2025, Wiley

    Ka Keat Lim, luigi gnudi

  3. Nogo-B Promotes Endoplasmic Reticulum Stress-Mediated Autophagy in Endothelial Cells of Diabetic Nephropathy

    Article • Antioxidants & Redox Signaling, October 2024, Mary Ann Liebert Inc

    luigi gnudi

  4. Ten years trajectories of estimated glomerular filtration rate (eGFR) in a multiethnic cohort of people with type 1 diabetes and preserved renal function

    Article • BMJ Open, September 2024, BMJ

    luigi gnudi

  5. Diabetic kidney disease in type 1 diabetes: challenges and differences from type 2 diabetes

    Article • Metabolism, February 2024, Elsevier

    luigi gnudi

  6. Effect of active vitamin-D on left ventricular mass index: Results of a randomized controlled trial in type 2 diabetes and chronic kidney disease

    Article • American Heart Journal, July 2023, Elsevier

    luigi gnudi

  7. Reduced Levels of the Antiaging Hormone Klotho are Associated With Increased Aortic Stiffness in Diabetic Kidney Disease

    Article • Kidney International Reports, July 2023, Elsevier

    luigi gnudi

  8. Effect of Continuous Positive Airway Pressure on Glucose and Lipid Profiles in Patients With Obstructive Sleep Apnoea: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Article • Archivos de Bronconeumología, June 2023, Elsevier

    luigi gnudi

  9. The Pillars for Renal Disease Treatment in Patients with Type 2 Diabetes

    Article • Pharmaceutics, April 2023, MDPI AG

    luigi gnudi

  10. Renal disease in patients with type 2 diabetes: Magnitude of the problem, risk factors and preventive strategies

    Article • La Presse Médicale, March 2023, Elsevier

    luigi gnudi

  11. Impact of treatment with active vitamin D calcitriol on bone turnover markers in people with type 2 diabetes and stage 3 chronic kidney disease

    Article • Bone, January 2023, Elsevier

    luigi gnudi

  12. Metabolism, Clinical and Experimental: seventy years young and growing

    Article • Metabolism, December 2022, Elsevier

    luigi gnudi

  13. Does Dapagliflozin influence arterial stiffness and levels of circulating anti-aging hormone soluble Klotho in people with type 2 diabetes and kidney disease? Results of a randomized parallel group clinical trial

    Article • Frontiers in Cardiovascular Medicine, September 2022, Frontiers

    luigi gnudi

  14. Effect of calcitriol treatment on arterial stiffness in people with type 2 diabetes and stage 3 chronic kidney disease

    Article • British Journal of Clinical Pharmacology, August 2022, Wiley

    luigi gnudi

  15. African Caribbean Ethnicity Is an Independent Predictor of Significant Decline in Kidney Function in People With Type 1 Diabetes

    Article • Diabetes Care, August 2022, American Diabetes Association

    luigi gnudi

  16. Diabetes and Kidney disease: metformin

    Article • January 2022, Springer Science + Business Media

    luigi gnudi

  17. Kidney disease in diabetes: From mechanisms to clinical presentation and treatment strategies

    Article • Metabolism, November 2021, Elsevier

    luigi gnudi

  18. Vascular growth factors as potential new treatment in cardiorenal syndrome in diabetes

    Article • European Journal of Clinical Investigation, May 2021, Wiley

    luigi gnudi

  19. Calcitonin Gene-Related Peptide Protects Against Cardiovascular Dysfunction Independently of Nitric Oxide In Vivo

    Article • Hypertension, April 2021, Wolters Kluwer Health

    luigi gnudi

  20. Mitochondrial dysfunction as a mechanistic biomarker in patients with non-alcoholic fatty liver disease (NAFLD)

    Article • Mitochondrion, March 2021, Elsevier

    luigi gnudi

  21. The endoplasmic reticulum stress and the unfolded protein response in kidney disease: Implications for vascular growth factors

    Article • Journal of Cellular and Molecular Medicine, October 2020, Wiley

    luigi gnudi

  22. A case for measuring both cellular and cell‐free mitochondrial DNA as a disease biomarker in human blood

    Article • The FASEB Journal, July 2020, Wiley

    luigi gnudi

  23. Diabetic Nephropathy: An Overview

    Article • November 2019, Springer Science + Business Media

    luigi gnudi

  24. Overexpression of Circulating Soluble Nogo-B Improves Diabetic Kidney Disease by Protecting the Vasculature

    Article • Diabetes, June 2019, American Diabetes Association

    luigi gnudi, David Long

  25. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

    Article • New England Journal of Medicine, June 2019, New England Journal of Medicine (NEJM/MMS)

    Prof Giacomo Garibotto, luigi gnudi

  26. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

    Article • The Lancet, May 2019, Elsevier

    Prof Alexander P Maxwell, luigi gnudi

  27. VEGFC Reduces Glomerular Albumin Permeability and Protects Against Alterations in VEGF Receptor Expression in Diabetic Nephropathy

    Article • Diabetes, November 2018, American Diabetes Association

    luigi gnudi

  28. The Future: Experimental Therapies for Renal Disease in Diabetes

    Article • Nephron, September 2018, Karger Publishers

    luigi gnudi

  29. Reduced Levels of Anti-Ageing Hormone Klotho Predict Renal Function Decline in Type 2 Diabetes

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2018, Endocrine Society

    luigi gnudi

  30. Diabetic nephropathy: Is there a role for oxidative stress?

    Article • Free Radical Biology and Medicine, February 2018, Elsevier

    luigi gnudi

  31. RETRACTED ARTICLE: Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes

    Article • Diabetologia, October 2017, Springer Science + Business Media

    luigi gnudi

  32. A pragmatic lifestyle modification programme reduces the incidence of predictors of cardio-metabolic disease and dysglycaemia in a young healthy urban South Asian population: a randomised controlled trial

    Article • BMC Medicine, August 2017, Springer Science + Business Media

    luigi gnudi

  33. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

    Article • New England Journal of Medicine, June 2017, New England Journal of Medicine (NEJM/MMS)

    Professor Vladimir V Rafalskiy, luigi gnudi

  34. Increased Arterial Stiffness is an Independent Predictor of Renal Function Decline in Patients With Type 2 Diabetes Mellitus Younger Than 60 Years

    Article • Journal of the American Heart Association, March 2017, Wolters Kluwer Health

    luigi gnudi

  35. Perturbations of the anti-ageing hormone Klotho in patients with type 1 diabetes and microalbuminuria

    Article • Diabetologia, February 2017, Springer Science + Business Media

    luigi gnudi

  36. Management of patients with diabetes and CKD: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

    Article • Kidney International, December 2016, Elsevier

    luigi gnudi

  37. Diabetic Nephropathy: Perspective on Novel Molecular Mechanisms

    Article • Trends in Endocrinology and Metabolism, November 2016, Elsevier

    luigi gnudi

  38. The anti-ageing hormone klotho induces Nrf2-mediated antioxidant defences in human aortic smooth muscle cells

    Article • Journal of Cellular and Molecular Medicine, October 2016, Wiley

    luigi gnudi

  39. Improvements in stage of change correlate to changes in dietary intake and clinical outcomes in a 5-year lifestyle intervention in young high-risk Sri Lankans

    Article • Preventive Medicine, September 2016, Elsevier

    luigi gnudi

  40. The effect of dietary changes on distinct components of the metabolic syndrome in a young Sri Lankan population at high risk of CVD

    Article • British Journal Of Nutrition, June 2016, Cambridge University Press

    luigi gnudi

  41. Angiopoietins and diabetic nephropathy

    Article • Diabetologia, May 2016, Springer Science + Business Media

    luigi gnudi

  42. Diabetic Nephropathy: Proteinuria, Inflammation, and Fibrosis

    Article • Journal of Diabetes Research, January 2016, Hindawi Publishing Corporation

    luigi gnudi

  43. Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetes

    Article • Diabetes Obesity and Metabolism, December 2015, Wiley

    Professor Vladimir V Rafalskiy, luigi gnudi

  44. Altered circulating mitochondrial DNA and increased inflammation in patients with diabetic retinopathy

    Article • Diabetes Research and Clinical Practice, December 2015, Elsevier

    Dr Afshan N Malik, luigi gnudi

  45. Vascular growth factors play critical roles in kidney glomeruli

    Article • Clinical Science, November 2015, Portland Press Ltd.

    David Long, luigi gnudi

  46. Diabetic nephropathy: What does the future hold?

    Article • International Urology and Nephrology, October 2015, Springer Science + Business Media

    luigi gnudi

  47. A Pilot Study to Evaluate the Efficacy of Class IV Lasers on Nonhealing Neuroischemic Diabetic Foot Ulcers in Patients With Type 2 Diabetes

    Article • Diabetes Care, September 2015, American Diabetes Association

    luigi gnudi

  48. The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial

    Article • The Lancet Diabetes & Endocrinology, September 2015, Elsevier

    luigi gnudi

  49. Preventing diabetic renal disease: the potential reno-protective effects of SGLT2 inhibitors

    Article • The British Journal of Diabetes, September 2015, SAGE Publications

    luigi gnudi

  50. Altered Mitochondrial Function, Mitochondrial DNA and Reduced Metabolic Flexibility in Patients With Diabetic Nephropathy

    Article • EBioMedicine, June 2015, Elsevier

    Dr Afshan N Malik, luigi gnudi

  51. Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min)

    Article • Nephrology Dialysis Transplantation, May 2015, Oxford University Press (OUP)

    luigi gnudi

  52. Beat it early: putative renoprotective haemodynamic effects of oral hypoglycaemic agents

    Article • Nephrology Dialysis Transplantation, April 2015, Oxford University Press (OUP)

    luigi gnudi

  53. A new chance to beat diabetic kidney disease: innate immunity and MCP-1: a matter of good and bad macrophages?

    Article • Nephrology Dialysis Transplantation, March 2015, Oxford University Press (OUP)

    luigi gnudi

  54. Influence of depression and anxiety on circulating endothelial progenitor cells in patients with acute coronary syndromes

    Article • Human Psychopharmacology Clinical and Experimental, March 2015, Wiley

    luigi gnudi

  55. Diabetes mellitus, a complex and heterogeneous disease, and the role of insulin resistance as a determinant of diabetic kidney disease

    Article • Nephrology Dialysis Transplantation, December 2014, Oxford University Press (OUP)

    luigi gnudi

  56. N-3 PUFA increase bioavailability and function of endothelial progenitor cells

    Article • Food & Function, May 2014, Royal Society of Chemistry

    luigi gnudi

  57. An Ongoing Role of α-Calcitonin Gene–Related Peptide as Part of a Protective Network Against Hypertension, Vascular Hypertrophy, and Oxidative Stress

    Article • Hypertension, May 2014, Wolters Kluwer Health

    luigi gnudi

  58. Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease

    Article • New England Journal of Medicine, December 2013, New England Journal of Medicine (NEJM/MMS)

    Professor john j mcmurray, luigi gnudi

  59. Glucose-lowering drugs in patients with chronic kidney disease: a narrative review on pharmacokinetic properties

    Article • Nephrology Dialysis Transplantation, December 2013, Oxford University Press (OUP)

    luigi gnudi

  60. Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes

    Article • New England Journal of Medicine, October 2013, New England Journal of Medicine (NEJM/MMS)

    Professor JOSE F VILELA-MARTIN, Filipa Costa, Professor Yuriy M. Sirenko, Massimo Volpe, Professor Dragan B Djordjevic, luigi gnudi

  61. Targeted Glomerular Angiopoietin-1 Therapy for Early Diabetic Kidney Disease

    Article • Journal of the American Society of Nephrology, September 2013, American Society of Nephrology

    David Long, luigi gnudi

  62. Effect of Renin-Angiotensin System Blockade on Soluble Klotho in Patients with Type 2 Diabetes, Systolic Hypertension, and Albuminuria

    Article • Clinical Journal of the American Society of Nephrology, August 2013, American Society of Nephrology

    luigi gnudi

  63. Albuminuria is associated with too few glomeruli and too much testosterone

    Article • Kidney International, June 2013, Elsevier

    David Long, luigi gnudi

  64. Lower endothelial progenitor cell number, family history of cardiovascular disease and reduced HDL-cholesterol levels are associated with shorter leukocyte telomere length in healthy young adults

    Article • Nutrition Metabolism and Cardiovascular Diseases, March 2013, Elsevier

    luigi gnudi

  65. A Role for TRPV1 in Influencing the Onset of Cardiovascular Disease in Obesity

    Article • Hypertension, January 2013, Wolters Kluwer Health

    luigi gnudi

  66. VEGF and angiopoietins in diabetic glomerulopathy: How far for a new treatment?

    Article • Metabolism, December 2012, Elsevier

    luigi gnudi

  67. Effect of Spironolactone and Amiloride on Thiazolidinedione-Induced Fluid Retention in South Indian Patients with Type 2 Diabetes

    Article • Clinical Journal of the American Society of Nephrology, November 2012, American Society of Nephrology

    Mr Nandakumar Parthasarathy, luigi gnudi

  68. Pioglitazone Improves In Vitro Viability and Function of Endothelial Progenitor Cells from Individuals with Impaired Glucose Tolerance

    Article • PLOS One, November 2012, PLOS

    luigi gnudi

  69. Podocytes and the struggle against glucose toxicity: New targets for treatment?

    Article • Metabolism, August 2012, Elsevier

    luigi gnudi

  70. Cellular and molecular mechanisms of diabetic glomerulopathy

    Article • Nephrology Dialysis Transplantation, May 2012, Oxford University Press (OUP)

    luigi gnudi

  71. High Prevalence of Cardio-Metabolic Risk Factors in a Young Urban Sri-Lankan Population

    Article • PLOS One, February 2012, PLOS

    luigi gnudi

  72. Elevated levels of renal and circulating Nop-7-associated 2 (NSA2) in rat and mouse models of diabetes, in mesangial cells in vitro and in patients with diabetic nephropathy

    Article • Diabetologia, November 2011, Springer Science + Business Media

    Dr Afshan N Malik, luigi gnudi

  73. DIABRISK - SL Prevention of cardio-metabolic disease with life style modification in young urban Sri Lankan's - study protocol for a randomized controlled trial

    Article • Trials, September 2011, Springer Science + Business Media

    luigi gnudi

  74. Reduced circulating endothelial progenitor cell number in healthy young adult hyperinsulinemic men

    Article • Nutrition Metabolism and Cardiovascular Diseases, July 2011, Elsevier

    luigi gnudi

  75. Circulating Vascular Progenitor Cells and Central Arterial Stiffness in Polycystic Ovary Syndrome

    Article • PLOS One, May 2011, PLOS

    luigi gnudi

  76. Endothelial Factors and Diabetic Nephropathy

    Article • Diabetes Care, April 2011, American Diabetes Association

    luigi gnudi

  77. Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial

    Article • The Lancet, June 2010, Elsevier

    luigi gnudi

  78. Renin angiotensin aldosterone system (RAAS) inhibitors in the prevention of early renal disease in diabetes

    Article • F1000 Medicine Reports, March 2010, F1000Research

    luigi gnudi

  79. Circulating Vascular Progenitor Cells in Patients With Type 1 Diabetes and Microalbuminuria

    Article • Diabetes Care, January 2010, American Diabetes Association

    luigi gnudi

  80. Peroxisome Proliferator-Activated Receptor-γ Agonist Rosiglitazone Prevents Albuminuria but Not Glomerulosclerosis in Experimental Diabetes

    Article • American Journal of Nephrology, January 2010, Karger Publishers

    luigi gnudi

  81. P-67: Use of recombinant adenovirus-mediated gene transfer to investigate the effects of dominant negative ras on the activation of PI3 kinase and glucose transport in 3T3L1 adipocytes

    Article • Experimental and Clinical Endocrinology & Diabetes, July 2009, Thieme Publishing Group

    luigi gnudi

  82. Mechanical forces and TGF 1 reduce podocyte adhesion through  3 1 integrin downregulation

    Article • Nephrology Dialysis Transplantation, May 2009, Oxford University Press (OUP)

    luigi gnudi

  83. Inducible Overexpression of sFlt-1 in Podocytes Ameliorates Glomerulopathy in Diabetic Mice

    Article • Diabetes, October 2008, American Diabetes Association

    luigi gnudi

  84. Molecular mechanisms of proteinuria in diabetes

    Article • Biochemical Society Transactions, September 2008, Portland Press Ltd.

    luigi gnudi

  85. Roles of Angiopoietins in Kidney Development and Disease: Figure 1.

    Article • Journal of the American Society of Nephrology, September 2008, American Society of Nephrology

    David Long, luigi gnudi

  86. Angiopoietin-1 therapy enhances fibrosis and inflammation following folic acid-induced acute renal injury

    Article • Kidney International, August 2008, Elsevier

    David Long, luigi gnudi

  87. ACCORD and ADVANCE: a tale of two studies on the merits of glycaemic control in type 2 diabetic patients

    Article • Nephrology Dialysis Transplantation, March 2008, Oxford University Press (OUP)

    luigi gnudi

  88. Fluorescence-based sensing of glucose using engineered glucose/galactose-binding protein: A comparison of fluorescence resonance energy transfer and environmentally sensitive dye labelling strategies

    Article • Biochemical and Biophysical Research Communications, January 2008, Elsevier

    luigi gnudi

  89. Future Strategies to Prevent Renal Microvascular Disease Complications in Diabetes

    Article • Future Cardiology, December 2007, Taylor & Francis

    luigi gnudi

  90. Serum intact parathyroid hormone in diabetic patients on haemodialysis: what is the treatment goal?

    Article • Nephrology Dialysis Transplantation, August 2007, Oxford University Press (OUP)

    luigi gnudi

  91. Mechanical Forces in Diabetic Kidney Disease

    Article • Journal of the American Society of Nephrology, August 2007, Wolters Kluwer Health

    luigi gnudi

  92. Podocyte-Specific Expression of Angiopoietin-2 Causes Proteinuria and Apoptosis of Glomerular Endothelia

    Article • Journal of the American Society of Nephrology, July 2007, American Society of Nephrology

    David Long, luigi gnudi

  93. The link between mechanical stretch and glucose metabolism--a conceptual advance in understanding diabetic (and non diabetic?) renal disease

    Article • Nephrology Dialysis Transplantation, September 2006, Oxford University Press (OUP)

    luigi gnudi

  94. Glucose induces increases in levels of the transcriptional repressor Id2 via the hexosamine pathway

    Article • AJP Endocrinology and Metabolism, April 2006, American Physiological Society

    luigi gnudi

  95. The link between Glut-1 and hypertension in diabetic nephropathy

    Article • Current Hypertension Reports, January 2006, Springer Science + Business Media

    luigi gnudi

  96. Glucose-dependent changes in NAD(P)H-related fluorescence lifetime of adipocytes and fibroblasts in vitro: Potential for non-invasive glucose sensing in diabetes mellitus

    Article • Journal of Photochemistry and Photobiology B Biology, August 2005, Elsevier

    luigi gnudi

  97. Mechanical Stretch Induces Monocyte Chemoattractant Activity via an NF-κB-Dependent Monocyte Chemoattractant Protein-1-Mediated Pathway in Human Mesangial Cells

    Article • Journal of the American Society of Nephrology, March 2005, Wolters Kluwer Health

    luigi gnudi

  98. Nateglinide alone or with metformin safely improves glycaemia to target in patients up to an age of 84

    Article • Diabetes Obesity and Metabolism, August 2004, Wiley

    luigi gnudi

  99. Non-Invasive Glucose Monitoring by NAD(P)H Autofluorescence Spectroscopy in Fibroblasts and Adipocytes: A Model for Skin Glucose Sensing

    Article • Diabetes Technology & Therapeutics, October 2003, Mary Ann Liebert Inc

    luigi gnudi

  100. GLUT-1 Overexpression

    Article • Hypertension, July 2003, Wolters Kluwer Health

    luigi gnudi

  101. IGF-I induces vascular endothelial growth factor in human mesangial cells via a Src-dependent mechanism11See Editorial by Cooper and Thomas, p. 1584.

    Article • Kidney International, April 2003, Elsevier

    luigi gnudi

  102. P38 mitogen-activated protein kinase mediates hexosamine-induced TGFβ1 mRNA expression in human mesangial cells

    Article • Diabetologia, April 2003, Springer Science + Business Media

    luigi gnudi

  103. Mechanical stretch-induced fibronectin and transforming growth factor-beta1 production in human mesangial cells is p38 mitogen-activated protein kinase-dependent.

    Article • Diabetes, April 2000, American Diabetes Association

    luigi gnudi

  104. Inhibition of DNA Synthesis by a Farnesyltransferase Inhibitor Involves Inhibition of the p70s6k Pathway

    Article • Journal of Biological Chemistry, February 1999, Elsevier

    luigi gnudi

  105. Multiple Signal Transduction Pathways Link Na+/K+-ATPase to Growth-related Genes in Cardiac Myocytes

    Article • Journal of Biological Chemistry, June 1998, Elsevier

    luigi gnudi

  106. Activation of the Ras Mitogen-activated Protein Kinase-Ribosomal Protein Kinase Pathway Is Not Required for the Repression of Phosphoenolpyruvate Carboxykinase Gene Transcription by Insulin

    Article • Journal of Biological Chemistry, February 1998, Elsevier

    luigi gnudi

  107. Amelioration of Insulin Resistance in Streptozotocin Diabetic Mice by Transgenic Overexpression of GLUT4 Driven by an Adipose-Specific Promoter1

    Article • Endocrinology, April 1997, Endocrine Society

    luigi gnudi

  108. High-Fat Feeding Impairs Insulin-Stimulated GLUT4 Recruitment via an Early Insulin-Signaling Defect

    Article • Diabetes, February 1997, American Diabetes Association

    luigi gnudi

  109. Adenovirus-Mediated Gene Transfer of Dominant Negative Rasasn17in 3T3L1 Adipocytes Does Not Alter Insulin-Stimulated PI3-Kinase Activity or Glucose Transport

    Article • Molecular Endocrinology, January 1997, Endocrine Society

    luigi gnudi

  110. Overexpression of Ha-ras Selectively in Adipose Tissue of Transgenic Mice

    Article • Journal of Biological Chemistry, May 1996, Elsevier

    luigi gnudi

  111. Over-expression of GLUT4 selectively in adipose tissue in transgenic mice: Implications for nutrient partitioning

    Article • Proceedings of The Nutrition Society, March 1996, Cambridge University Press

    luigi gnudi

  112. Insulin Regulation of Phosphoenolpyruvate Carboxykinase Gene Expression Does Not Require Activation of the Ras/Mitogen-activated Protein Kinase Signaling Pathway

    Article • Journal of Biological Chemistry, January 1996, Elsevier

    luigi gnudi

  113. High level overexpression of glucose transporter-4 driven by an adipose-specific promoter is maintained in transgenic mice on a high fat diet, but does not prevent impaired glucose tolerance.

    Article • Endocrinology, March 1995, Endocrine Society

    luigi gnudi

  114. Alcohol Intake Impairs Glucose Counterregulation During Acute Insulin-Induced Hypoglycemia in IDDM Patients: Evidence for a Critical Role of Free Fatty Acids

    Article • Diabetes, November 1993, American Diabetes Association

    luigi gnudi

  115. Effects of different plasma glucose concentrations on lipolytic and ketogenic responsiveness to epinephrine in type I (insulin-dependent) diabetic subjects.

    Article • The Journal of Clinical Endocrinology & Metabolism, April 1993, Endocrine Society

    luigi gnudi

  116. Ketone Body Metabolism in NIDDM: Effect of Sulfonylurea Treatment

    Article • Diabetes, August 1992, American Diabetes Association

    luigi gnudi

  117. The effects of different plasma insulin concentrations on lipolytic and ketogenic responses to epinephrine in normal and Type 1 (insulin-dependent) diabetic humans

    Article • Diabetologia, February 1992, Springer Science + Business Media

    luigi gnudi

  118. Renal metabolism of C peptide in type I (insulin-dependent) diabetic patients

    Article • Journal of Diabetic Complications, April 1991, Elsevier

    luigi gnudi

  119. Effects of chronic alcohol intake on carbohydrate and lipid metabolism in subjects with type ii (non-insulin-dependent) diabetes

    Article • The American Journal of Medicine, January 1991, Elsevier

    luigi gnudi

  120. Habitual leisure‐time physical activity is associated with differences in various risk factors for coronary artery disease

    Article • Journal of Internal Medicine, December 1989, Wiley

    luigi gnudi

  121. Hyperinsulinemia and Coronary Artery Disease

    Article • New England Journal of Medicine, August 1989, New England Journal of Medicine (NEJM/MMS)

    luigi gnudi

  122. Risk Factors for Coronary Artery Disease in Healthy Persons with Hyperinsulinemia and Normal Glucose Tolerance

    Article • New England Journal of Medicine, March 1989, New England Journal of Medicine (NEJM/MMS)

    luigi gnudi